Per Stålhandske

Per is an emeritus cancer researcher and molecular biologist.  He has a diverse career spanning academic research, industrial development, and quality management. He holds a PhD in Medical Genetics from Uppsala University. 

Per has served as a Senior Scientist and Quality Assurance (QA) Manager at companies such as Oasmia Pharmaceutical and Sangtec Medical. He was the Co-Founder and first CEO of cSens AB, a company focused on unique technical concepts for diagnostic oncology products. In 2016, cSens merged with Biovica International AB.

For the Galevant Institute Per serves as an expert advisor on science and technology within the oncology domain.